| Title |
Endoscopic retroperitoneal adrenalectomy for adrenal metastases / |
| Authors |
Simutis, Gintaras ; Lengvenis, Givi ; Beiša, Virgilijus ; Strupas, Kęstutis |
| DOI |
10.1155/2014/806194 |
| Full Text |
|
| Is Part of |
International journal of endocrinology.. New York : Hindawi Publishing Corporation. 2014, vol. 2014, Art. ID 806194, p. [1-7].. ISSN 1687-8337 |
| Abstract [eng] |
Objectives. To evaluate whether retroperitoneal approach for adrenalectomy is a safe and effective treatment for adrenal metastases (AM). Methods. From June 2004 to January 2014, nine consecutive patients with AM were treated with endoscopic retroperitoneal adrenalectomy (ERA). A retrospective study was conducted, and clinical data, tumor characteristics, and oncologic outcomes were acquired and analyzed. Results. Renal cancer was the primary site of malignancy in 44.4% of cases. The mean operative time was 132 ± 10.4 min. There were 5 synchronous and 4 metachronous AM. One patient required conversion to transperitoneal laparoscopic procedure. No mortality or perioperative complications were observed. The median overall survival was 11 months (range: 2–42 months). Survival rates of 50% and 25% were identified at 1 and 3 years, respectively. At the end of the study, 4 patients were alive with a mean observed follow-up of 20 months. No patients presented with local tumor relapse or port-site metastases. Conclusions. This study shows that ERA is a safe and effective procedure for resection of AM and advances the surgical treatment of adrenal disease. The use of the retroperitoneal approach for adrenal tumors less than 6 cm can provide very favorable surgical outcomes. |
| Published |
New York : Hindawi Publishing Corporation |
| Type |
Journal article |
| Language |
English |
| Publication date |
2014 |
| CC license |
|
